Skip to search formSkip to main contentSkip to account menu
  • Publications
  • Influence
Orienting patients to greater opioid safety: models of community pharmacy-based naloxone
TLDR
This case study briefly describes and provides two US state-specific examples of innovative policy models of pharmacy-based naloxone, implemented to reduce overdose events and improve opioid safety: Collaborative Pharmacy Practice Agreements and Pharmacy Standing Orders.
View on Springer
Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.
View on PubMed
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment
TLDR
How the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased are discussed.
View on Taylor & Francis
Opioid overdose prevention.
TLDR
A pilot randomized control trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose and use of non‐pharmacological strategies for pain relief in addiction treatment patients with chronic pain.
View on PubMed
Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy
TLDR
This opinion paper challenges the status quo by calling on all pharmacists to embrace evidence‐based opioid stewardship and harm reduction practices, contribute to the medical management of opioid use disorder, and address the misconceptions and prejudices that serve as barriers to effective, compassionate patient care.
View on Wiley
An interprofessional education workshop to develop health professional student opioid misuse knowledge, attitudes, and skills.
View on PubMed
Missed opportunities for HIV screening in pharmacies and retail clinics.
TLDR
For widespread pharmacy-based testing to become a reality, policymakers and corporate pharmacy leadership would need to develop innovative solutions to the existing time pressures of pharmacists' behind-the-counter functions and absence of reimbursement for direct patient care services.
View on PubMed
Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose
TLDR
Overall the findings reveal factors at multiple levels which may play a role in likelihood of obtaining naloxone at the pharmacy, and can be used to inform interventions seeking to increase provision of pharmacy-based n aloxone.
View on Springer
Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.
TLDR
Mandating the prescribing of naloxone quickly expands access to this life-saving medication for more people in more places after 90 days before and after they took effect in Arizona, Florida, Rhode Island, Vermont, and Virginia.
View on PubMed
Pharmacy leaders' beliefs about how pharmacies can support a sustainable approach to providing naloxone to the community.
View on PubMed
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License